Pazopanib
Pazopanib
Pazopanib (pronounced pah-zoh-PAN-ib) is a type of antineoplastic agent used in the treatment of certain types of cancer, including renal cell carcinoma and soft tissue sarcoma.
Etymology
The name "Pazopanib" is derived from the combination of the words "pazo", which is a prefix used in pharmaceutical naming to denote a drug's function, and "anib", which is a suffix used to denote a drug's class. In this case, "pazo" refers to the drug's function as a tyrosine kinase inhibitor, and "anib" denotes its class as an angiogenesis inhibitor.
Usage
Pazopanib is used to treat advanced renal cell carcinoma (RCC) and advanced soft tissue sarcoma (STS) in patients who have received prior chemotherapy. It works by blocking the action of an abnormal protein that signals cancer cells to multiply, helping to slow or stop the spread of cancer cells.
Side Effects
Common side effects of Pazopanib include nausea, diarrhea, changes in hair color, and high blood pressure. Serious side effects can include liver problems, heart failure, and a type of high blood pressure called hypertension.
Related Terms
- Antineoplastic agent
- Tyrosine kinase inhibitor
- Angiogenesis inhibitor
- Renal cell carcinoma
- Soft tissue sarcoma
- Chemotherapy
- Nausea
- Diarrhea
- High blood pressure
- Hypertension
External links
- Medical encyclopedia article on Pazopanib
- Wikipedia's article - Pazopanib
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski